Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVALENT study of COVID-19 vaccine immune response in lung transplant populations
NL-OMON22289Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2021
- Countries
- 1
01
Overview
Open-label trial of SARS-CoV-2 vaccine in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by University Medical Center Groningen. Primary endpoint: Antibody response after second vaccine dose. Started Feb 2021; status: active, not recruiting.
02
Drugs
SARS-CoV-2 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON22289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22289.